Indeed, amongst the most frequently mutated genetic drivers of NSCLC, namely KEAP1, STK11 and TP53, KEAP1 mutations are associated with the worst patient survival in two independent patient cohorts [49, 56]. Here, TP53 is linked to non-small cell lung carcinoma.